Neuropeptide Y Shows Promise for Pain Relief, Anxiety, and Blood Pressure Control
Neuropeptide Y has emerging therapeutic potential as a painkiller, anxiety reducer, and blood pressure regulator, mediated through distinct receptor subtypes.
Quick Facts
What This Study Found
NPY mediates analgesia and hyperalgesia through distinct receptor subtypes, alongside established roles in blood pressure regulation and anxiety modulation.
Key Numbers
How They Did This
Literature review synthesizing evidence on NPY's analgesic, anxiolytic, and antihypertensive effects across receptor subtypes.
Why This Research Matters
NPY receptors could provide new drug targets for pain, anxiety, and hypertension that work through fundamentally different mechanisms than current medications.
The Bigger Picture
NPY is one of the most abundant neuropeptides in the brain. Understanding its diverse receptor-specific effects opens multiple therapeutic avenues for common conditions.
What This Study Doesn't Tell Us
Review article; most evidence from animal studies. NPY-based therapeutics face delivery challenges as the peptide doesn't easily cross the blood-brain barrier.
Questions This Raises
- ?Can NPY receptor-specific drugs provide effective pain relief without the side effects of opioids?
- ?Which NPY receptor subtype is optimal for anxiety treatment?
Trust & Context
- Key Stat:
- Triple therapeutic potential NPY shows distinct analgesic, anxiolytic, and antihypertensive effects through different receptor subtypes
- Evidence Grade:
- Moderate evidence from a comprehensive review. Strong preclinical data but limited clinical translation at time of publication.
- Study Age:
- Published in 1996. NPY receptor-targeted drug development has continued, with some compounds reaching clinical trials.
- Original Title:
- The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive.
- Published In:
- Drugs, 52(3), 371-89 (1996)
- Authors:
- Munglani, R, Hudspith, M J, Hunt, S P
- Database ID:
- RPEP-00372
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is neuropeptide Y?
NPY is one of the most abundant signaling peptides in the brain. It regulates many functions including appetite, stress response, blood pressure, and pain perception. It works through multiple receptor subtypes, each mediating different effects.
How can one peptide both reduce and increase pain?
NPY acts through different receptor subtypes that have opposite effects. Activation of certain NPY receptors reduces pain (analgesia), while others increase pain sensitivity (hyperalgesia). This means targeted drugs hitting the right receptor could provide specific pain relief.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00372APA
Munglani, R; Hudspith, M J; Hunt, S P. (1996). The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive.. Drugs, 52(3), 371-89.
MLA
Munglani, R, et al. "The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive.." Drugs, 1996.
RethinkPeptides
RethinkPeptides Research Database. "The therapeutic potential of neuropeptide Y. Analgesic, anxi..." RPEP-00372. Retrieved from https://rethinkpeptides.com/research/munglani-1996-the-therapeutic-potential-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.